

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
TLRY
Tilray
$1.49
Strengths

Earnings are forecast to grow

Trading below its fair value
Chart
$1.15 (+29.57%)
$0.6 (+148.33%)
$0.4 (+272.50%)
$1.54 (-3.25%)
TLRY has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

TLRY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY

Revenue increase YoY

Loss widens YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
TLRY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
TLRY Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayTLRY Earnings
The TTM reflects 12-month period, providing review of TLRY financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is TLRY current stock price?
What are TLRY stock strengths?
What risks are associated with TLRY stock?
When is TLRY next earnings report?
What is TLRY market cap and volume?
What is TLRY's current Stock IQ?
Should I buy TLRY stock right now?
Is TLRY a Strong Buy right now?
What does a 'Strong Buy' rating mean for TLRY?
What does a 'Strong Sell' rating mean for TLRY?
What factors influence TLRY's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
TLRY
Tilray
Current Price
$1.49
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value
Chart
$1.15 (+29.57%)
$0.6 (+148.33%)
$0.4 (+272.50%)
$1.54 (-3.25%)
TLRY Analysts Opinion
TLRY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY

Revenue increase YoY

Loss widens YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
TLRY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
TLRY Street view is extremely bullish and have positive views on the near-term outlook
TLRY has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels.
TLRY Earnings
The TTM data reflects the most recent 12-month period, providing overview of TLRY financial performance.
TLRY Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
TLRY Latest Analysis
Tilray Brands Stock Is on Track for Its Best Year Since 2018. Has It Become a Good Buy?. Key PointsCanada legalized marijuana seven years ago.
Wed Oct 22, 2025
Should You Buy This Stock After It Recorded a Surprise Profit?. Key PointsTilray Brands has gained momentum this year due to developments in cannabis regulation.
Thu Oct 16, 2025
Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use. ) shares are trading higher on Wednesday after a cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here’.s what investors need to know.Analyzing insurance claims for 15 to 20 million Americans annually from 2007-2020 researchers found that states with medical cannabis laws saw the rate of patients with opioid prescriptions fall by an average of
Wed Oct 15, 2025
Tilray Brands (TLRY) Upgraded to Buy: What Does It Mean for the Stock?. Tilray Brands (TLRY) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Wed Oct 15, 2025
Should You Buy TLRY Stock After Encouraging Q1 Results?. Tilrays return to profitability stronger cash flow and expanding global cannabis and beverage operations highlight its renewed growth story.
Wed Oct 15, 2025
Whats Going On With Tilray Brands Stock Today?. ) shares are According to TLRY stock has gained over 36% in the past month. Investors can gain exposure to the stock via ).On Monday the cannabis company stated it plans to extend its medical marijuana footprint into Panama through a new joint venture with local The ...
Tue Oct 14, 2025
Tilray Medical Announces Expansion Plans in Panama Strengthening Global Cannabis Leadership and Accelerating International Growth. NEW YORK Oct. 13 2025 (GLOBE NEWSWIRE) -- Tilray Medical (Tilray) a division of Tilray Brands Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions transforming healthcare has announced plans to expand its medical ca
Mon Oct 13, 2025
Tilray Brands Inc. (NASDAQ:TLRY) Q1 2026 Earnings Call Transcript. Tilray Brands Inc. (NASDAQ:TLRY) Q1 2026 Earnings Call Transcript October 9 2025 Tilray Brands Inc. beats earnings expectations. Reported EPS is $-0.00022 expectations were $-0.03. Operator: Thank you for joining today’.s conference call to discuss Tilray Brands Inc. financial results for the first quarter fiscal year 2026 ended August 31 2025. All lines have been [….]
Mon Oct 13, 2025
Tilray Reports Strong Q1-2026 Earnings As The Cannabis Sector Rallies.
Fri Oct 10, 2025
Tilray Brands (TLRY) Hits All-Time High on Stellar Q1 Earnings. We recently published 10 Big Names With Whopping Gains. 6 Jump All-Time Highs. Tilray Brands Inc. (NASDAQ:TLRY) is one of the best performers on Thursday. Tilray Brands soared to a new all-time high on Thursday after posting a stellar earnings performance in the first quarter of the fiscal year 2026. During the session Tilray Brands [….]
Fri Oct 10, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TLRY Stock trends
TLRY Stock performance
TLRY Stock analysis
TLRY investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.